President Trump sent letters to 17 of the world's biggest prescription drugmakers last week calling on them to reduce prices ...

Trump’s main effort, which he cited on August 3, centers on getting drugmakers to offer the same price in the US as they do in Europe and other peer countries, the so-called “Most Favored Nation” ...

Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...

Major pharma manufacturers have a 29 September deadline to adjust their drug prices relative to other developed countries.

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

In follow-up to the May 12th “Delivering Most Favored Nation Prescription Drug Pricing to American Patients” Executive Order, ...

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the ...

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...

The White House set a 60-day deadline for drugmakers to agree on “most favored nation” prices for Medicaid as well as for ...

Most Favored Nation’s War on R&D would mean fewer remedies and therapies. This is perfect for an aging, ailing nation in which 10,000 new baby boomers turn 65 and qualify for Medicare every day.

President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical ...